





| 카탈로그 번호 | HB011196 |
|---|---|
| 설명 |
Rezetamig (HB011196) is a research-grade recombinant antibody targeting CD22. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| 종 반응성 | Human |
| 응용 분야 | ELISA, Bioactivity: FCM, Functional assay, Research in vivo |
| 숙주 종 | Human |
| 클론성 | Monoclonal |
| 이소타입 | immunoglobulin half G4-kappa_G4(VH-h-CH2-CH3) |
| 테스트된 응용 분야 | WB |
| 타겟 | B-cell receptor CD22, B-lymphocyte cell adhesion molecule, BL-CAM, CD22, SIGLEC2, Sialic acid-binding Ig-like lectin 2, Siglec-2, T-cell surface antigen Leu-14, CD3E, CD3e, T-cell surface antigen T3/Leu-4 epsilon chain, T-cell surface glycoprotein CD3 epsilon chain, T3E |
| 내독소 수준 | < 10 EU/mg |
| 순도 | >95% as determined by SDS-PAGE. |
| 정제 | Protein A/G purified from cell culture supernatant. |
| 등록번호 | P20273 & P07766 |
| 형태 | Liquid |
| 저장 완충액 | 0.01M PBS pH 7.4. 데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요. |
| 안정성 및 저장 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 대체 이름 | Bispecific, Bivalent, CAS: 2795115-07-8 |
| 배경 | Rezetamig is an anti-CD3E/CD22 monoclonal antibody. |
| 참고사항 | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype Control | Human IgG4 (S228P) Recombinant Isotype Control Antibody (13R4) (HP298207) |

Detects Recombinant Human CD22 Protein, C-His (Cat No.: HB011021) in indirect ELISA.

SDS-PAGE for Research Grade Rezetamig.

Western blot analysis was performed using anti-CD22 monoclonal antibody at 1ug/mL on various samples.
Lane 1: recombinant human CD22 (Catalog No: HB011021)
Lane 2: negative control






+86-027-65523339
중국 우한시 심둔사로 666번지 C동, 우한, 430206

中文
English
한국어
日本語
Español
Français
Русский